Association of constipation and fecal incontinence with attention-deficit/hyperactivity disorder

Connor McKeown1, Elizabeth Hisle-Gorman, Matilda Eide

  • 1Uniformed Services University of the Health Sciences, 4301 Jones Bridge Rd, Bethesda, MD 20814. cade.nylund@usuhs.edu.

Pediatrics
|October 23, 2013
PubMed

Insights

Children with attention-deficit/hyperactivity disorder (ADHD) have a higher risk of developing functional constipation and fecal incontinence. ADHD medication did not affect the rates of these defecation disorders.

Area of Science:

  • Pediatric Gastroenterology
  • Child Psychiatry
  • Behavioral Pediatrics

Background:

  • Functional constipation and fecal incontinence are prevalent pediatric gastrointestinal issues.
  • Behavioral problems, including attention-deficit/hyperactivity disorder (ADHD), are often associated with these conditions.

Purpose of the Study:

  • To investigate the hypothesis that a diagnosis of ADHD increases the risk for functional constipation and fecal incontinence in children.

Main Methods:

  • A retrospective cohort study analyzed data from the military health system database for children aged 4-12 years.
  • Diagnostic codes for ADHD, constipation, and fecal incontinence were used to identify cases.
  • Relative risks and incidence rate ratios (IRRs) were calculated, with a subgroup analysis for children receiving medical therapy for ADHD.

Main Results:

  • Children with ADHD showed a significantly higher prevalence of constipation (4.1% vs 1.5%) and fecal incontinence (0.9% vs 0.15%) compared to those without ADHD.
  • Children with ADHD had substantially more healthcare visits for constipation (IRR 3.39) and fecal incontinence (IRR 7.74).
  • Medical therapy for ADHD did not significantly alter visit rates for constipation or fecal incontinence.

Conclusions:

  • Children diagnosed with ADHD are significantly more prone to experiencing constipation and fecal incontinence.
  • Current medical therapies for ADHD do not appear to influence the frequency of visits for these defecation disorders.
Abstract

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.4K
Irritable Bowel Syndrome01:23

Irritable Bowel Syndrome

DefinitionIrritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by recurrent combinations of abdominal pain, bloating, diarrhea, or constipation.Pathophysiology of irritable bowel syndromeIts pathophysiology is multifactorial, involving disturbances in motility, sensory processing, microbial balance, barrier integrity, and gut–brain communication. These mechanisms interact to produce symptoms that vary across IBS subtypes.Altered Motility...
73
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
1.5K
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
1.1K
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
908
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
1.0K